Please ensure Javascript is enabled for purposes of website accessibility

Stock Market Today: CVS Ends Tobacco Sales and HBO Boosts Time Warner

By Demitri Kalogeropoulos - Feb 5, 2014 at 9:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Why CVS Caremark, Time Warner, and Merck stocks are on the move today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Expect a flat start to the stock market today, as the Dow Jones Industrial Average (^DJI 0.03%) lost an insignificant 15 points in premarket trading this morning. Global stocks were mostly higher in overnight trading, led by a 1.23% gain in Japan's Nikkei index.

The ADP national employment report today showed a gain of 175,000 nonfarm private-sector jobs in the U.S. last month, on par with what economists expected but below the 227,000 jobs added in December. The official jobs report from the U.S. Bureau of Labor Statistics, which the ADP report aims to track, is due out on Friday morning.

Meanwhile, news is breaking this morning on several stocks that could see heavy trading in today's session, including CVS Caremark (CVS 1.92%), Merck (MRK 1.58%), and Time Warner (TWX).

CVS Caremark announced today that it will stop the sale of cigarettes and other tobacco products across its 7,600 stores and pharmacies nationwide by October of this year. Citing the fact that smoking is the leading cause of premature disease and death, the company said that selling tobacco products is "inconsistent with our purpose" of supporting the health of patients and customers. CVS also plans to lead a national program aimed at helping smokers quit. The company expects to lose approximately $2 billion in annual revenue from tobacco sales, which will hurt 2014's profit by between $0.06 and $0.09 a share. CVS' stock is down 1.7% in premarket trading.

Merck today posted fourth-quarter earnings results that were in line with Wall Street's estimates. Sales fell by 4%, to $11.3 billion, and adjusted profit rose by 6% to reach $0.88 a share. The pharmaceutical giant's drug portfolio notched flat sales after accounting for foreign currency changes, as strength in a number of products offset the decline of the asthma drug Singulair, which fell 69% last year after losing patent protection. Merck also provided its outlook for 2014, which called for sales and adjusted profits to both fall slightly, to roughly $43 billion and $3.43 a share, respectively. Merck's stock is up 1.6% in premarket trading.

Finally, Time Warner this morning announced that fourth-quarter sales rose by 6% to $8.6 billion, above analysts' expectations for $8.4 billion. Earnings ticked higher by 1%, to reach $1.17 a share. The company's Warner Bros. division got a boost from the popular theatrical releases of Gravity and The Hobbit: The Desolation of Smaug in the quarter. The HBO business also kicked in higher revenue as subscription rates improved. Time Warner's stock is up 1.4% in premarket trading.


 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
^DJI
$31,261.90 (0.03%) $8.77
Merck & Co., Inc. Stock Quote
Merck & Co., Inc.
MRK
$93.55 (1.58%) $1.46
Time Warner Inc. Stock Quote
Time Warner Inc.
TWX
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$94.93 (1.92%) $1.79

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/21/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.